Profound Medical earnings were -$19.6M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest PROF earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$6.7M, down 25.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PROF reported annual earnings of -$19.3M, with -9.3% growth. The next PROF earnings date is May 7, 2025.
What were Profound Medical's earnings last quarter?
On PROF's earnings call on Invalid Date, Profound Medical (NASDAQ: PROF) reported Q4 2024 earnings per share (EPS) of -$0.14, up 54.87% year over year. Total PROF earnings for the quarter were -$6.73 million. In the same quarter last year, Profound Medical's earnings per share (EPS) was -$0.31.
The next PROF earnings call is Invalid Date. Add PROF to your watchlist to be reminded of Profound Medical's next earnings date.
What was PROF's earnings growth in the past year?
As of Profound Medical's earnings date in Invalid Date, Profound Medical's earnings has grown year over year. PROF earnings in the past year totalled -$19.59 million.
Is Profound Medical profitable or losing money?
As of the last Profound Medical earnings report, Profound Medical is currently losing money. Profound Medical's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$19.32 million, a 9.29% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.